Compound Summary
药名: | Cyclopamine |
分子式: | C27H41NO2 |
Smiles: | CC1CC2C(C(C3(O2)CCC4C5CC=C6CC(CCC6(C5CC4=C3C)C)O)C)NC1 |
成分: | HBIN022330;HBIN000389 |
OB_score: | 55.42172 |
CAS_id: | 4449-51-8 |
SymMap_id: | SMIT10216;SMIT14866 |
TCMID_id: | 4521;30863 |
TCMSP_id: | MOL009027 |
PubChem_id: | 442972 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE006087 | Buibus Fritillariae Pallidiflorae | 伊贝母 | To remove heat from the lung, to resolve phlegm, and to reduce nodules./Lung heat cough, sticky phlegm and oppression in chest, consumption cough and hemoptysis, scrofula, swollen welling abscess. | |||
TCMBANKHE004399 | Veratrum nigrum | 藜芦 | To promote vomiting, dispel wind and transform phlegm, lower blood pressure, kill worms./Wind stroke with congesting phlegm, epilepsy, malaria, scab and lichen, malign sore. | |||
TCMBANKHE004802 | Veratrum album | 白藜芦醇; 白藜芦 | ||||
TCMBANKHE005359 | Bulbus Fritillariae Cirrhosae | 川贝母 | To remove heat, moisten the lung, resolve phlegm and relieve cough./Lung heat cough, dry cough, chronic bronchitis, infection of upper respiratory tract, tuberculosis, gastric ulcer, duodenal ulcer, yin vacuity taxation cough, cough with phlegm and blood. | |||
TCMBANKHE005572 | Veratrum californicum | 加州藜芦 | ||||
TCMBANKHE005874 | 玳玳花 | Oppression in chest due to glomus, distending pain in stomach duct and abdomen, vomiting, reduced food intake. | ||||
TCMBANKHE007281 | Taxus yunnanensis | 云南红豆杉 | ||||
TCMBANKHE008310 | Cortex Eucommiae | 杜仲 | To tonify the liver and the kidney, to strengthen the tendons and bones, and to prevent miscarrige./Hypertension, kidney vacuity lumbago, weakness in sinews and bones, stirring fetus in pregnancy. | |||
TCMBANKHE008167/YEM-39/XU-672 | Cortex Eucommiae|Eucommia ulmoides Oliv.|Eucommia ulmoides | 杜仲 | 杜仲 | 云南民族药物志:第一卷|贵州省岑巩县平庄镇师兆村 | To tonify the liver and the kidney, to strengthen the tendons and bones, and to prevent miscarrige./Hypertension, kidney vacuity lumbago, weakness in sinews and bones, stirring fetus in pregnancy. | 阿昌族/傣族/德昂族/哈尼族/景颇族/傈僳族/彝族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000017 | Liver Cirrhosis | disease | Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 28052321 |
TCMBANKDI000018 | Pancreatic Neoplasm | disease | Digestive System Diseases; Neoplasms; Endocrine System Diseases | 23786654 |
TCMBANKDI000032 | Hepatitis C, Chronic | disease | Digestive System Diseases; Infections | 21793033 |
TCMBANKDI000048 | Neoplasms | group | Neoplasms | 23146903 |
TCMBANKDI000052 | Osteoporosis | disease | Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 30352124 |
TCMBANKDI000083 | Infarction, Middle Cerebral Artery | disease | Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases | 23696546 |
TCMBANKDI000089 | Asthma | disease | Respiratory Tract Diseases; Immune System Diseases | 29867080 |
TCMBANKDI000090 | Acute kidney injury | disease | Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 31461626 |
TCMBANKDI000160 | Hypersensitivity | group | Immune System Diseases | 29867080 |
TCMBANKDI001795 | Reperfusion Injury | disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 31461626 |
TCMBANKDI003324 | Cholangiocarcinoma | disease | Neoplasms | 23703673 |
TCMBANKDI006869 | Necrosis | phenotype | Pathological Conditions, Signs and Symptoms | 23172661 |
TCMBANKDI006871 | Hyperplasia | phenotype | Pathological Conditions, Signs and Symptoms | 23766265 |
TCMBANKDI007361 | Multiple Myeloma | disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 23847194 |
TCMBANKDI007930 | Bile Duct Neoplasms | group | Digestive System Diseases; Neoplasms | 23703673 |
TCMBANKDI008386 | oligodendroglioma | disease | Neoplasms | 23474492 |
TCMBANKDI011242 | Metaplasia | phenotype | Pathological Conditions, Signs and Symptoms | 29867080 |
TCMBANKDI012424 | Neoplasm Invasiveness | phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | 23786654 |
TCMBANKDI013888 | Fibrosis | phenotype | Pathological Conditions, Signs and Symptoms | 22302193 |
TCMBANKDI015452 | Thyroid Neoplasm | disease | Neoplasms; Endocrine System Diseases | 25078145 |
TCMBANKDI015496 | Liver neoplasms | group | Digestive System Diseases; Neoplasms | 21793033 |
TCMBANKDI020561 | Renal fibrosis | disease | Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 22302193 |
TCMBANKDI020745 | Neointima | disease | Pathological Conditions, Signs and Symptoms | 23766265 |
TCMBANKDI023109 | Neointimal hyperplasia | disease | - | 23766265 |
TCMBANKDI024649 | Neuroblastoma | disease | Neoplasms | 21803487 |
TCMBANKDI026694 | Adrenocortical carcinoma | disease | Neoplasms; Endocrine System Diseases | 24712566 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000202 | RUNX2 | AML3; CBF-alpha-1; CBFA1; CCD; CCD1; CLCD; OSF-2; OSF2; PEA2aA; PEBP2aA | RUNX family transcription factor 2 |
TCMBANKGE000233 | DES | CDCD3; CSM1; CSM2; LGMD1D; LGMD1E; LGMD2R | desmin |
TCMBANKGE000280 | VIM | - | vimentin |
TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
TCMBANKGE000877 | ABCG2 | ABC15; ABCP; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; UAQTL1 | ATP binding cassette subfamily G member 2 (Junior blood group) |
TCMBANKGE000878 | MIR7-3HG | C19orf30; Huh7; LINC00306; NCRNA00306; PGSF1; uc002mbe.2 | MIR7-3 host gene |
TCMBANKGE000879 | SERPINE2 | GDN; GDNPF; PI-7; PI7; PN-1; PN1; PNI | serpin family E member 2 |
TCMBANKGE000880 | Psl1 | Tpa | promotion susceptibility QTL 1 |
TCMBANKGE000881 | PLAT | T-PA; TPA | plasminogen activator, tissue type |
TCMBANKGE000882 | SERPINE1 | PAI; PAI-1; PAI1; PLANH1 | serpin family E member 1 |
TCMBANKGE000883 | MIR25 | MIRN25; hsa-mir-25; miR-25 | microRNA 25 |
TCMBANKGE000884 | FN1 | CIG; ED-B; FINC; FN; FNZ; GFND; GFND2; LETS; MSF; SMDCF | fibronectin 1 |
TCMBANKGE000885 | SPP1 | BNSP; BSPI; ETA-1; OPN | secreted phosphoprotein 1 |
TCMBANKGE000886 | SOX9 | CMD1; CMPD1; SRA1; SRXX2; SRXY10 | SRY-box transcription factor 9 |
TCMBANKGE000887 | PPM1D | IDDGIP; JDVS; PP2C-DELTA; WIP1 | protein phosphatase, Mg2+/Mn2+ dependent 1D |
TCMBANKGE000888 | PLK2 | SNK; hPlk2; hSNK | polo like kinase 2 |
TCMBANKGE000889 | HFE | HFE1; HH; HLA-H; MVCD7; TFQTL2 | homeostatic iron regulator |
TCMBANKGE000890 | FUT1 | H; HH; HSC | fucosyltransferase 1 (H blood group) |
TCMBANKGE000891 | ABCC3 | ABC31; EST90757; MLP2; MOAT-D; MRP3; cMOAT2 | ATP binding cassette subfamily C member 3 |
TCMBANKGE000892 | SP7 | OI11; OI12; OSX; osterix | Sp7 transcription factor |
TCMBANKGE000893 | IBSP | BNSP; BSP; BSP-II; SP-II | integrin binding sialoprotein |
TCMBANKGE000894 | Bglap2 | BGP2; Bglap1; Bgp; Og2; mOC-B | bone gamma-carboxyglutamate protein 2 |
TCMBANKGE000895 | SUFU | JBTS32; PRO1280; SUFUH; SUFUXL | SUFU negative regulator of hedgehog signaling |
TCMBANKGE000896 | SFRP1 | FRP; FRP-1; FRP1; FrzA; SARP2 | secreted frizzled related protein 1 |
TCMBANKGE000897 | GLI3 | ACLS; GCPS; GLI3-190; GLI3FL; PAP-A; PAPA; PAPA1; PAPB; PHS; PPDIV | GLI family zinc finger 3 |
TCMBANKGE000898 | MYC | MRTL; MYCC; bHLHe39; c-Myc | MYC proto-oncogene, bHLH transcription factor |
TCMBANKGE000899 | GLI2 | CJS; HPE9; PHS2; THP1; THP2 | GLI family zinc finger 2 |
TCMBANKGE000900 | GALNT1 | GALNAC-T1 | polypeptide N-acetylgalactosaminyltransferase 1 |
TCMBANKGE000901 | ANGPT1 | AGP1; AGPT; ANG1 | angiopoietin 1 |
TCMBANKGE000902 | HAS2 | - | hyaluronan synthase 2 |
TCMBANKGE000903 | PTGS1 | COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS | prostaglandin-endoperoxide synthase 1 |
TCMBANKGE000904 | PTCH1 | BCNS; NBCCS; PTC; PTC1; PTCH | patched 1 |
TCMBANKGE000905 | GATA6 | - | GATA binding protein 6 |
TCMBANKGE000906 | FOXA2 | HNF-3-beta; HNF3B; TCF3B | forkhead box A2 |
TCMBANKGE000907 | SPDEF | PDEF; bA375E1.3 | SAM pointed domain containing ETS transcription factor |
TCMBANKGE000908 | MUC5AC | MUC5; TBM; leB; mucin | mucin 5AC, oligomeric mucus/gel-forming |
TCMBANKGE000909 | GLI1 | GLI; PAPA8; PPD1 | GLI family zinc finger 1 |
TCMBANKGE000910 | SLC22A3 | EMT; EMTH; OCT3 | solute carrier family 22 member 3 |
TCMBANKGE000911 | ITK | EMT; LPFS1; LYK; PSCTK2 | IL2 inducible T cell kinase |
TCMBANKGE000912 | SHH | HHG1; HLP3; HPE3; MCOPCB5; SMMCI; ShhNC; TPT; TPTPS | sonic hedgehog signaling molecule |
TCMBANKGE000913 | IHH | BDA1; HHG2 | Indian hedgehog signaling molecule |
TCMBANKGE000914 | SMOX | C20orf16; PAO; PAO-1; PAO1; PAOH; PAOH1; SMO | spermine oxidase |
TCMBANKGE000915 | BMPR2 | BMPR-II; BMPR3; BMR2; BRK-3; POVD1; PPH1; T-ALK | bone morphogenetic protein receptor type 2 |
TCMBANKGE000916 | SMO | CRJS; FZD11; Gx; SMOH | smoothened, frizzled class receptor |
TCMBANKGE001010 | TNFRSF10A | APO2; CD261; DR4; TRAILR-1; TRAILR1 | TNF receptor superfamily member 10a |
TCMBANKGE001011 | TNFSF10 | APO2L; Apo-2L; CD253; TL2; TNLG6A; TRAIL | TNF superfamily member 10 |
TCMBANKGE001097 | HIF1A | HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78 | hypoxia inducible factor 1 subunit alpha |
TCMBANKGE001109 | ALPP | ALP; ALPI; IAP; PALP; PLAP; PLAP-1 | alkaline phosphatase, placental |
TCMBANKGE001113 | ACTA2 | ACTSA | actin alpha 2, smooth muscle |
TCMBANKGE001123 | CTNNB1 | CTNNB; EVR7; MRD19; NEDSDV; armadillo | catenin beta 1 |
TCMBANKGE001146 | SNAI1 | SLUGH2; SNA; SNAH; SNAIL; SNAIL1; dJ710H13.1 | snail family transcriptional repressor 1 |
TCMBANKGE001148 | VEGFA | MVCD1; VEGF; VPF | vascular endothelial growth factor A |
TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
TCMBANKGE001172 | HSP90AA1 | EL52; HEL-S-65p; HSP86; HSP89A; HSP90A; HSP90N; HSPC1; HSPCA; HSPCAL1; HSPCAL4; HSPN; Hsp103; Hsp89; Hsp90; LAP-2; LAP2 | heat shock protein 90 alpha family class A member 1 |
TCMBANKGE001173 | MCL1 | BCL2L3; EAT; MCL1-ES; MCL1L; MCL1S; Mcl-1; TM; bcl2-L-3; mcl1/EAT | MCL1 apoptosis regulator, BCL2 family member |
TCMBANKGE001181 | TGFB1 | CED; DPD1; IBDIMDE; LAP; TGF-beta1; TGFB; TGFbeta | transforming growth factor beta 1 |